DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the us, and treats about 250,000 patients globally each year. Government payers dominate us dialysis reimbursement. DaVita receives about two thirds of us sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of the us patients treated, they represent nearly all of the profits generated by DaVita in the us dialysis business.

DaVita India

DaVita Labs Careers

DaVita Kidney Care

DaVita means “to give life,” reflecting our proud history as leaders in dialysis—an essential, life-sustaining treatment for those living with end stage kidney disease (ESKD). Today, our mission is to minimize the devastating impacts of kidney disease across the full spectrum of kidney health care.

At DaVita, we’re a community first and a company second. We care for our teammates with the same intensity with which we care for our patients—and encourage our teammates to bring their hearts to work. That is, we can be the same people inside and outside of work because for us, it’s not work, it’s our passion. 

Interested in joining our Village? There are over 75,000 careers and counting. Visit careers.davita.com to start your career adventure.  

msh id	COM:DAVITA
symbol	DVA
name	DaVita Inc.
homepage url	https://www.davita.com
country	US
sector	Healthcare
industry	Medical - Care Facilities
market	STOCKS
employee count	70K
crunchbase url	-
linkedin url	-
founders	-

market cap	12.22B
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	82.76
growth score 28	49.07
growth score 90	29.62
growth score 365	61.51

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0.02
growth cost of revenue	0.1
growth depreciation and amortization	0.04
growth ebitda	0.14
growth ebitda ratio	0.09
growth eps	-
growth eps diluted	-
growth general and administrative expenses	0.09
growth gross profit	-0.1
growth gross profit ratio	-0.14

COM:DAVITA

DaVita Inc.

Last Close

161.40

21/11 21:00

Market Cap

13.46B

Beta: -

Volume Today

707.70K

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	10.54B
cost of revenue	10.54B
depreciation and amortization	745.44M
ebitda	2.35B
ebitda ratio	0.19
eps	7.62
eps diluted	7.42
operating expenses	1.47B
operating income	1.6B
operating income ratio	0.13

accounts receivables	172.36M
capital expenditure	-567.99M
cash at beginning of period	338.99M
cash at end of period	464.63M
inventory	143.11M
working capital ttm	597.43M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-